Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel axial chiral naphthalene-pyrrole phosphine catalyst enables efficient asymmetric synthesis with simplified process flow and enhanced supply chain reliability for pharmaceutical intermediates.
This patent introduces a novel axial chiral naphthalene-pyrrole phosphine catalyst with mild reaction conditions and high enantioselectivity, enabling cost-effective production of chiral intermediates for pharmaceutical applications.
Patent CN118271227B enables scalable production of pyrrole intermediates through mild silver catalysis, ensuring cost-effective manufacturing and reliable supply chain solutions.
Patent CN115925722B enables industrial-scale synthesis of key tazobactam intermediate through optimized copper halide halogenation, eliminating pollution and enhancing supply chain reliability for pharmaceutical manufacturers.
Patent CN118878452B enables high-yield synthesis under mild conditions with significant cost savings for reliable pharmaceutical intermediate supply chains.
Patent CN102040561B introduces a green synthesis method using acidic ionic liquids for benzotriazole UV absorbers enabling high-yield production with reduced waste and simplified supply chain management.
Novel chiral pyrrole synthesis method enables high-yield production with exceptional enantioselectivity, enhancing pharmaceutical supply chain reliability and cost efficiency.
Patent CN110041235B introduces NTFTS reagent for efficient trifluoroacetophenone synthesis enabling cost reduction and reliable supply in pharmaceutical manufacturing
Patent CN116199614B enables high-yield synthesis of chiral catalysts with up to 98% ee, offering cost-effective and scalable production for pharmaceutical intermediates.
Patent CN119874717B enables mild synthesis of high-purity antitumor intermediates with scalable production, offering cost-effective supply chain solutions for pharmaceutical manufacturers.
Novel metal-free synthesis enables high stereoselectivity and scalable production of fluorinated intermediates offering cost reduction and reliable supply for pharmaceutical manufacturing.
Novel Lewis acid-catalyzed method enables high-yield production of bioactive indole-piperidine compounds under mild conditions enhancing supply chain reliability and cost efficiency for pharmaceutical intermediates
Patent CN113880781B enables scalable production of high-purity triazole intermediates using glucose as carbon source, enhancing supply chain reliability and reducing manufacturing costs.
Patent CN119060057B introduces a mild chiral phosphoric acid catalyzed route achieving high stereoselectivity and yield for indolocyclopentanes compounds with significant cost reduction potential in pharmaceutical manufacturing.
Novel chiral phosphoric acid-catalyzed method enables high-yield enantioselective production with significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN113307790B delivers efficient heavy-metal-free triazole synthesis with simplified processing and reliable supply chain advantages for pharmaceutical intermediates.
Patent CN113880781B introduces glucose-based synthesis of high-purity trifluoromethyl triazoles ensuring scalable production with reduced environmental impact for pharmaceutical manufacturing.
Breakthrough axial chiral catalyst enables high-purity API intermediates with enhanced stereoselectivity and scalable manufacturing advantages.
Patent CN121045008A enables high-purity axial chiral biaryl amino phenol synthesis under mild conditions avoiding heavy metals for cost-effective pharmaceutical intermediate manufacturing.
Patent CN106188044B introduces a transition metal-free iodine-catalyzed method for heterocyclic compound synthesis with high yield and purity. This approach significantly reduces manufacturing costs while enhancing supply chain reliability for pharmaceutical applications.